Device Trial Radar · NCT00589797
Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease
Last checked: Nov 20, 2026Latest source record: Dec 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Aesculap Implant SystemsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 10, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn whether an investigational device called the Activ-L Artificial Disc is safe and effective in the treatment of degenerative disc disease of the lower (lumbar) spine.
Conditions
- Degenerative Disc Disease
Interventions
Activ-L Artificial DiscDevice
Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.
ProDisc-L Total Disc Replacement or Charité Artificial DiscDevice
Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Success at 24 Months Relative to BaselineTime frame: 24 months
5 more outcomes with a free account
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Scripps Memorial Hospital La Jolla
La Jolla, California
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.